These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Polycomb Group Protein Pcgf6 Acts as a Master Regulator to Maintain Embryonic Stem Cell Identity. Yang CS; Chang KY; Dang J; Rana TM Sci Rep; 2016 Jun; 6():26899. PubMed ID: 27247273 [TBL] [Abstract][Full Text] [Related]
26. Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors. Wen W; Zhang JP; Xu J; Su RJ; Neises A; Ji GZ; Yuan W; Cheng T; Zhang XB Stem Cell Reports; 2016 Jun; 6(6):873-884. PubMed ID: 27161365 [TBL] [Abstract][Full Text] [Related]
27. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines. Okada M; Yoneda Y Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232 [TBL] [Abstract][Full Text] [Related]
28. Direct reprogramming of fibroblasts into epiblast stem cells. Han DW; Greber B; Wu G; Tapia N; Araúzo-Bravo MJ; Ko K; Bernemann C; Stehling M; Schöler HR Nat Cell Biol; 2011 Jan; 13(1):66-71. PubMed ID: 21131959 [TBL] [Abstract][Full Text] [Related]
29. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors. Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141 [TBL] [Abstract][Full Text] [Related]
30. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Seki T; Yuasa S; Oda M; Egashira T; Yae K; Kusumoto D; Nakata H; Tohyama S; Hashimoto H; Kodaira M; Okada Y; Seimiya H; Fusaki N; Hasegawa M; Fukuda K Cell Stem Cell; 2010 Jul; 7(1):11-4. PubMed ID: 20621043 [No Abstract] [Full Text] [Related]
32. Two Histone Variants TH2A and TH2B Enhance Human Induced Pluripotent Stem Cell Generation. Huynh LM; Shinagawa T; Ishii S Stem Cells Dev; 2016 Feb; 25(3):251-8. PubMed ID: 26649967 [TBL] [Abstract][Full Text] [Related]
33. Generation of Human iPSCs by Protein Reprogramming and Stimulation of TLR3 Signaling. Liu C; Ameen M; Himmati S; Thomas D; Sayed N Methods Mol Biol; 2021; 2239():153-162. PubMed ID: 33226618 [TBL] [Abstract][Full Text] [Related]
34. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc. Tavernier G; Wolfrum K; Demeester J; De Smedt SC; Adjaye J; Rejman J Biomaterials; 2012 Jan; 33(2):412-7. PubMed ID: 21993235 [TBL] [Abstract][Full Text] [Related]
35. Directed Myogenic Differentiation of Human Induced Pluripotent Stem Cells. Shoji E; Woltjen K; Sakurai H Methods Mol Biol; 2016; 1353():89-99. PubMed ID: 25971915 [TBL] [Abstract][Full Text] [Related]
36. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Li R; Liang J; Ni S; Zhou T; Qing X; Li H; He W; Chen J; Li F; Zhuang Q; Qin B; Xu J; Li W; Yang J; Gan Y; Qin D; Feng S; Song H; Yang D; Zhang B; Zeng L; Lai L; Esteban MA; Pei D Cell Stem Cell; 2010 Jul; 7(1):51-63. PubMed ID: 20621050 [TBL] [Abstract][Full Text] [Related]
37. Mechanisms of iPS cell generation and beyond. Kaji K Keio J Med; 2017; 66(1):14. PubMed ID: 28356547 [TBL] [Abstract][Full Text] [Related]
38. Using low-risk factors to generate non-integrated human induced pluripotent stem cells from urine-derived cells. Wang L; Chen Y; Guan C; Zhao Z; Li Q; Yang J; Mo J; Wang B; Wu W; Yang X; Song L; Li J Stem Cell Res Ther; 2017 Nov; 8(1):245. PubMed ID: 29096702 [TBL] [Abstract][Full Text] [Related]